HI
IONS icon

HBK Investments’s Ionis Pharmaceuticals IONS Stock Holding History

HBK Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60,000
Closed -$2.4M – 208
2024
Q3 		$2.4M Buy
+60,000
New +$2.79M 0.03% 127
2018
Q1 		– Sell
-12,145
Closed -$611K – 1042
2017
Q4 		$611K Buy
+12,145
New +$666K ﹤0.01% 705
2014
Q2 		– Sell
-42,600
Closed -$1.84M – 975
2014
Q1 		$1.84M Buy
+42,600
New +$2.06M 0.03% 334
2013
Q4 		– Sell
-26,799
Closed -$1.01M – 948
2013
Q3 		$1.01M Buy
+26,799
New +$801K 0.01% 458

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

HBK Investments's IONS Position: Q4 2024 in Review

HBK Investments sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 60,000 shares — an estimated $2.4M sold.

HBK Investments first reported a position in IONS in Q3 2013 and held it in 4 quarters. The position peaked at $2.4M in Q3 2024. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • HBK Investments reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • HBK Investments sold 60,000 Ionis Pharmaceuticals shares in Q4 2024, an estimated $2.4M.
  • HBK Investments first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • HBK Investments's Ionis Pharmaceuticals position peaked at $2.4M in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on HBK Investments's 13F filing for Q4 2024, filed 14 Feb 2025.